Clinical Trials Directory

Trials / Completed

CompletedNCT01414452

Role of Adiponectin and Endothelial Progenitor Cells in Reperfusion Injury in Patients With Acute Myocardial Infarction

Reperfusion Injury and Cardiac Remodelling After Myocardial Infarction in Relation to Adiponectin Level, Circulating Endothelial Progenitor Cells and Endothelial Microparticles

Status
Completed
Phase
Study type
Observational
Enrollment
250 (actual)
Sponsor
Universiteit Antwerpen · Academic / Other
Sex
All
Age
Healthy volunteers
Not accepted

Summary

There is experimental evidence that low levels of adiponectin are associated with more reperfusion injury. In addition experimental studies have demonstrated that endothelial progenitor cells may have a favorable effect on remodeling, mainly through stimulation of neo-revascularisation. Clinical data on these issues are lacking. This clinical project studies the role of adiponectin, endothelial progenitor cells and endothelial microparticles in the ischaemia-reperfusion process and the compensatory ventricular remodelling in a population of 250 infarction patients treated with primary PCI. If the role of these factors could be confirmed in this clinical setting, those factors might represent a new target for therapeutic interventions in AMI patients.

Conditions

Timeline

Start date
2011-04-01
Primary completion
2012-12-01
Completion
2013-12-01
First posted
2011-08-11
Last updated
2015-07-21

Locations

1 site across 1 country: Belgium

Source: ClinicalTrials.gov record NCT01414452. Inclusion in this directory is not an endorsement.

Role of Adiponectin and Endothelial Progenitor Cells in Reperfusion Injury in Patients With Acute Myocardial Infarction (NCT01414452) · Clinical Trials Directory